EGFR and ovarian carcinoma: HB-EGF, probably released via the actions of enzymes a disintegrin and metalloproteinase 17 (ADAM17) [123,124] or cathepsin B [125], induces the transactivation of EGFR, which leads to increased proliferation of epithelial ovarian cancer cells [86].